Journal
PEDIATRIC DERMATOLOGY
Volume 37, Issue 4, Pages 754-755Publisher
WILEY
DOI: 10.1111/pde.14159
Keywords
JAK inhibitor; Janus kinase inhibitor; pediatric; segmental vitiligo; tofacitinib; topical; treatment; vitiligo
Categories
Ask authors/readers for more resources
Segmental vitiligo often presents in childhood and tends to be more recalcitrant to therapy than generalized vitiligo. Recently, Janus kinase inhibitors have emerged as a promising treatment option, with some reports suggesting that concomitant ultraviolet light exposure may enhance therapeutic response. Here, we present a child with segmental vitiligo who responded rapidly and completely to treatment with tofacitinib cream plus phototherapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available